Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management
A new consensus statement in The Lancet Diabetes and Endocrinology, from EASO, EFAD and ECPO, sets out what happens after the injection
We are now able to seamlessly support those interested in exploring if clinical interventions are right for them with WeightWatchers Clinic, as well as ensure they have a holistic resource for adopting healthy habits while adjusting to, and managing life on medications, with the WeightWatchers GLP-1 Program, said Sima Sistani, Chief Executive Officer, WeightWatchers
In the context of hunger, overeating and binge eating, bitter foods can be a wonderful tool to help reset a palate that has been overstimulated by highly processed, sweet, or salty foods